Linguistic Validation of the M. D. Anderson Symptom Inventory in Persian-Speaking Iranian Cancer Patients

被引:2
|
作者
Saadatpour, Leila [1 ]
Hemati, Simin [2 ]
Habibi, Farzaneh [1 ]
Behzadi, Erfan [1 ]
Hashemi-Jazi, Marsa Sadat [1 ]
Kheirabadi, Gholamreza [3 ]
Mirbagher, Leila [4 ]
Gholamrezaei, Ali [4 ]
机构
[1] Isfahan Univ Med Sci, Med Students Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Dept Radiotherapy Oncol, Esfahan, Iran
[3] Isfahan Univ Med Sci, Dept Psychiat, Esfahan, Iran
[4] Poursina Hakim Res Inst, Esfahan, Iran
关键词
Neoplasms; symptom assessment; validation studies; translations; QUALITY-OF-LIFE; EUROPEAN-ORGANIZATION; VERSION; TRANSLATION; QLQ-C30;
D O I
10.1016/j.jpainsymman.2015.03.018
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Various symptoms frequently affect cancer patients' quality of life. Appropriate assessment of these symptoms provides valuable data for cancer management. Objectives. This study aimed to validate the Persian version of the M. D. Anderson Symptom Inventory (MDASI-P). Methods. This cross-sectional study was conducted at four cancer treatment centers in two cities in Iran. Breast cancer and colorectal cancer patients aged 18 years and older were consecutively included in the study. The standard forward-backward translation method was applied. Patients completed the MDASI-P along with the previously validated Persian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30). Construct validity (factor analysis), criterion validity (against the EORTC QLQ-C30), and reliability (Cronbach's alpha) were analyzed. Results. A total of 146 breast cancer and 94 colorectal cancer patients were studied. Factor analysis for the symptom severity items resulted in a three-factor solution, further reduced to a two-factor solution: general symptoms and gastrointestinal symptoms. Correlation of the MDASI-P symptom severity items with corresponding EORTC QLQ-C30 symptom items (r = 0.48-0.75) and MDASI-P interference items with corresponding EORTC QLQ-C30 functioning domains (r = -0.46 to -0.23) supported the criterion validity. Cronbach's alpha was 0.90, 0.88, and 0.77 for the total questionnaire, symptom severity items, and the interference subscale, respectively. Conclusion. The MDASI-P is a feasible, valid, and reliable instrument for evaluation of symptoms in Persian-speaking cancer patients and can be used to improve symptom management in these patients. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:387 / +
页数:8
相关论文
共 29 条
  • [1] Validation and Application of the Arabic Version of the M. D. Anderson Symptom Inventory in Moroccan Patients With Cancer
    Nejmi, Mati
    Wang, Xin Shelley
    Mendoza, Tito R.
    Gning, Ibrahima
    Cleeland, Charles S.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 40 (01) : 75 - 86
  • [2] Assessing symptom distress in cancer patients - The M. D. Anderson Symptom Inventory
    Cleeland, CS
    Mendoza, TR
    Wang, XS
    Chou, C
    Harle, MT
    Morrissey, M
    Engstrom, MC
    CANCER, 2000, 89 (07) : 1634 - 1646
  • [3] Validation of the M. D. Anderson Symptom Inventory multiple myeloma module
    Jones, Desiree
    Vichaya, Elisabeth G.
    Wang, Xin Shelley
    Williams, Loretta A.
    Shah, Nina D.
    Thomas, Sheeba K.
    Johnson, Valen E.
    Champlin, Richard E.
    Cleeland, Charles S.
    Mendoza, Tito R.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [4] Development and Initial Validation of the Thyroid Cancer Module of the M. D. Anderson Symptom Inventory
    Gning, Ibrahima
    Trask, Peter C.
    Mendoza, Tito R.
    Harle, Margaret T.
    Gutierrez, Karla A.
    Kitaka, Sheila A.
    Sherman, Steven I.
    Cleeland, Charles S.
    ONCOLOGY, 2009, 76 (01) : 59 - 68
  • [5] Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients
    Chen, Ren-Wang
    Wang, Qiong
    Hu, Ting
    Xie, Yu-Xiu
    Chang, Hai-Yan
    Cheng, Jing
    CURRENT MEDICAL SCIENCE, 2022, 42 (02) : 426 - 433
  • [6] Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients
    Ren-wang Chen
    Qiong Wang
    Ting Hu
    Yu-xiu Xie
    Hai-yan Chang
    Jing Cheng
    Current Medical Science, 2022, 42 : 426 - 433
  • [7] Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer
    Sailors, Mary H.
    Bodurka, Diane C.
    Gning, Ibrahima
    Ramondetta, Lois M.
    Williams, Loretta A.
    Mendoza, Tito R.
    Agarwal, Sonika
    Sun, Charlotte C.
    Cleeland, Charles S.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (02) : 323 - 328
  • [8] Symptom Burden of Cancer Patients: Validation of the German M. D. Anderson Symptom Inventory: A Cross-Sectional Multicenter Study
    Schmidt, Heike
    Cleeland, Charles S.
    Bauer, Alexander
    Landenberger, Margarete
    Jahn, Patrick
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 49 (01) : 118 - 126
  • [9] Cancer-Related Symptom Assessment in France: Validation of the French M. D. Anderson Symptom Inventory
    Guirimand, Frederic
    Buyck, Jean-Francois
    Lauwers-Allot, Elisabeth
    Revnik, Julia
    Kerguen, Thierry
    Aegerter, Philippe
    Brasseur, Louis
    Cleeland, Charles S.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (04) : 721 - 733
  • [10] Cross-Cultural Adaptation and Validation of the Persian Version of the M. D. Anderson Dysphagia Inventory
    Sharifi, Fardin
    Qoreishi, Zahra Sadat
    Bakhtiyari, Jalal
    Ebadi, Abbas
    Houshyari, Mohammad
    Azghandi, Samira
    INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2024, 28 (02) : e288 - e293